Indian bid for relief from antibiotic countervailing duties rejected
EU ministers have largely ignored an Indian government request for the lowering of EU countervailing duties on imports of certain broad spectrum antibiotics from India.
EU ministers have largely ignored an Indian government request for the lowering of EU countervailing duties on imports of certain broad spectrum antibiotics from India.
This followed a reform of Indian subsidies, which the duties counteract. But ministers have decided to lower duties only for New Delhi's Ranbaxy Laboratories Ltd, (30.3% to 11.9%). The general rate remains at 32%.